```html

Water‑house‑Friderichsen Syndrome

Overview

Water‑house‑Friderichsen syndrome (WFS) is a rare, life‑threatening condition characterized by the sudden destruction of the adrenal glands, usually caused by a severe bacterial infection. The adrenal cortex is responsible for producing cortisol, aldosterone, and adrenal‑androgen hormones; loss of these glands leads to adrenal insufficiency and can precipitate shock, severe electrolyte disturbances, and death if not treated promptly.

Who it affects: The syndrome most frequently occurs in infants and young children, especially those younger than 5 years, but it can also affect adolescents, adults, and the elderly. Males are slightly more often reported than females (approximately 1.2 : 1). Cases are most common in low‑resource settings where meningococcal disease is endemic, yet sporadic cases appear worldwide.

Prevalence: True incidence is difficult to determine because many cases are fatal before a diagnosis can be confirmed. In the United States, meningococcal disease—which accounts for ≈ 80 % of WFS cases—affects about 1,000–1,500 individuals annually, and WFS complicates roughly 1–2 % of those infections (CDC). Globally, an estimated 1–5 cases per 1 million people per year are reported (WHO).

Symptoms

Symptoms develop rapidly—often within a few hours of the inciting infection—and can progress from mild to fulminant. The classic triad includes:

• High‑grade fever (often > 39 °C/102 °F) with chills.
• Severe hypotension (shock) that is refractory to fluid resuscitation.
• Purpura fulminans – striking, painless, dark purple spots that evolve into necrotic patches, most commonly on the trunk and extremities.

Additional signs and symptoms may include:

• Acute adrenal crisis – nausea, vomiting, abdominal pain, fatigue, and confusion.
• Electrolyte abnormalities – hyponatremia, hyperkalemia, and metabolic acidosis.
• Skin findings – petechiae, ecchymoses, and gangrenous lesions.
• Neurologic signs – meningitis‑like headache, neck stiffness, photophobia, seizures, or altered mental status.
• Respiratory distress – rapid breathing (tachypnea) and low oxygen saturation.
• Renal dysfunction – oliguria or anuria due to shock‑induced acute kidney injury.
• Coagulopathy – disseminated intravascular coagulation (DIC) manifested by prolonged PT/INR, low fibrinogen, and thrombocytopenia.

Because the presentation mirrors severe sepsis, a high index of suspicion is essential, especially when purpuric rash and shock coexist.

Causes and Risk Factors

Primary infectious triggers

• Neisseria meningitidis (meningococcus) – responsible for ≈ 70–80 % of cases. Serogroups B, C, W, and Y are most commonly implicated.
• Streptococcus pneumoniae – can cause WFS in both children and adults.
• Other gram‑negative bacteria – Haemophilus influenzae, Pseudomonas aeruginosa, and Gram‑negative rods in nosocomial settings.
• Viral and fungal agents – rare, but cases linked to severe influenza, varicella, and Candida have been reported.

Risk factors

• Age < 5 years (immune system immature).
• Deficiencies in complement components (e.g., C5‑C9 deficiency) that impair bacterial killing.
• Asplenia or functional hyposplenism (e.g., sickle‑cell disease).
• Immunosuppression – HIV infection, chemotherapy, or chronic corticosteroid use.
• Close contact with carriers of N. meningitidis (household members, dormitories, military barracks).
• Recent upper respiratory infection that may precede bacteremia.

Diagnosis

Prompt diagnosis hinges on clinical suspicion, rapid laboratory testing, and imaging when appropriate.

Initial laboratory work‑up

• Complete blood count (CBC) – often shows leukocytosis with left shift; thrombocytopenia is common.
• Serum electrolytes – hyponatremia, hyperkalemia, and low bicarbonate.
• Coagulation profile – prolonged PT/INR, aPTT, low fibrinogen, and D‑dimer elevation (reflecting DIC).
• Blood cultures – obtain before antibiotics; N. meningitidis grows in aerobic bottles within 24 h in ≥ 90 % of cases.
• Lumbar puncture (if no contraindication) – CSF analysis showing neutrophilic pleocytosis, low glucose, high protein, and positive Gram stain/culture.
• Serum cortisol and ACTH – markedly low cortisol with inappropriately normal or low ACTH supports adrenal insufficiency.

Imaging

• Abdominal CT or MRI – may reveal bilateral adrenal enlargement, hemorrhage, or necrosis.
• Chest X‑ray – to assess for pneumonia or pulmonary infiltrates associated with sepsis.

Diagnostic criteria (clinical)

According to the International Consensus on Adrenal Hemorrhage, WFS is diagnosed when all three are present:

1. Acute severe bacterial infection (most often meningococcemia).
2. Rapid onset of shock unresponsive to fluid resuscitation.
3. Bilateral adrenal hemorrhage demonstrated by imaging or autopsy.

Because waiting for imaging may delay treatment, clinicians often start therapy empirically based on the first two criteria.

Treatment Options

Management is a race against time: simultaneously treat the infection, replace adrenal hormones, and support organ function.

Antimicrobial therapy

• Empiric broad‑spectrum coverage immediately after cultures are drawn:
  • Third‑generation cephalosporin (e.g., ceftriaxone 2 g IV q12h) for meningococcal coverage.
  • Add vancomycin if methicillin‑resistant Staphylococcus aureus (MRSA) is a concern.
• Targeted therapy once the pathogen is identified:
  • N. meningitidis – continue ceftriaxone or switch to penicillin G if susceptible.
  • S. pneumoniae – high‑dose cefotaxime or ceftriaxone.
• Duration is generally 7–10 days for meningococcemia, longer (2–3 weeks) for meningitis or complications.

Adrenal hormone replacement

• Hydrocortisone 100 mg IV bolus, then 50 mg IV every 6 h (or continuous infusion 300 mg/24 h) to mimic physiological stress dosing.
• Fludrocortisone 0.05–0.1 mg PO daily once the patient stabilizes, to replace aldosterone and maintain sodium‑potassium balance.
• Monitoring: serum cortisol should rise > 18 µg/dL after 30–60 min; electrolytes are checked q4–6 h initially.

Supportive care

• Aggressive fluid resuscitation with isotonic crystalloids (e.g., normal saline) and, if needed, colloids.
• Vasopressor support (norepinephrine) for refractory hypotension.
• Management of DIC – transfuse platelets, fresh frozen plasma, or cryoprecipitate as guided by coagulation labs.
• Renal replacement therapy for acute kidney injury.
• Mechanical ventilation for respiratory failure.

Lifestyle and long‑term considerations

• Education on adrenal insufficiency: stress‑dosing steroids for illness, surgery, or trauma.
• Medical alert bracelet indicating lifelong corticosteroid dependence.
• Vaccinations: meningococcal conjugate (MenACWY) and serogroup B vaccines, pneumococcal vaccine, and annual influenza shot reduce future infection risk.

Living with Water‑house‑Friderichsen Syndrome

After acute recovery, most survivors require lifelong glucocorticoid and mineralocorticoid replacement.

Daily management tips

• Medication adherence – take hydrocortisone (or equivalent) exactly as prescribed; never skip doses.
• Emergency steroid kit – keep an injectable hydrocortisone or dexamethasone kit (100 mg) with a needle and alcohol swab for rapid self‑administration.
• Stress dosing – double or triple oral steroids during fever, dental work, or minor surgery; seek medical advice for major stress.
• Monitor electrolytes – periodic labs (every 3–6 months) to ensure sodium, potassium, and blood pressure remain stable.
• Regular follow‑up – endocrinology visits at least twice yearly, or more often if dosing changes.
• Vaccination schedule – maintain up‑to‑date immunizations; discuss revaccination after splenectomy or complement deficiency.
• Healthy lifestyle – balanced diet rich in fruits, vegetables, and adequate salt (if fludrocortisone dose is low); regular exercise as tolerated.

Psychosocial support

Living with a rare, potentially fatal condition can cause anxiety. Consider:

• Support groups (e.g., Addison’s Disease Self‑Help Group, which also covers adrenal insufficiency).
• Counseling or cognitive‑behavioral therapy for stress management.
• Educational resources from the NHS or the CDC.

Prevention

Because bacterial infection is the root cause, preventing invasive infection is the cornerstone.

• Vaccination – recommended for all infants, adolescents, and high‑risk adults:
  • Meningococcal conjugate (MenACWY) at 11–12 years, booster at 16 years.
  • Meningococcal B vaccine for ages 10–25 years (especially college students, military).
  • Pneumococcal vaccine (PCV13/PCV15 and PPSV23) per CDC schedule.
  • Annual influenza vaccination.
• Prophylactic antibiotics for close contacts of a confirmed meningococcal case (e.g., ciprofloxacin 500 mg single dose).
• Prompt treatment of upper respiratory infections – seek medical care for worsening sore throat, fever, or rash.
• Good hygiene – regular hand washing, avoiding sharing utensils or cigarettes with sick individuals.
• Screening for complement deficiencies in patients with recurrent meningococcal infections; vaccine and antibiotic prophylaxis are indicated.

Complications

If not recognized and treated within hours, WFS can lead to catastrophic outcomes.

• Irreversible adrenal insufficiency – lifelong dependence on steroids.
• Disseminated intravascular coagulation (DIC) – can cause multiorgan failure and massive bleeding.
• Acute renal failure – secondary to shock and DIC, may require dialysis.
• Neurologic sequelae – seizures, cognitive deficits, or peripheral neuropathy from meningitis.
• Amputations – severe peripheral gangrene from purpura fulminans.
• Mortality – reported case‑fatality rates range from 30 % to 70 % depending on speed of treatment and available intensive‑care resources (CDC, Mayo Clinic).

When to Seek Emergency Care

---

References:

1. Mayo Clinic. Water‑house‑Friderichsen syndrome. https://www.mayoclinic.org.
2. Centers for Disease Control and Prevention. Meningococcal disease fact sheet. https://www.cdc.gov.
3. World Health Organization. Meningitis. https://www.who.int.
4. National Institute of Allergy and Infectious Diseases. Meningococcal disease. https://www.niaid.nih.gov.
5. Cleveland Clinic. Adrenal crisis. https://my.clevelandclinic.org.
6. NIH National Center for Advancing Translational Sciences. Clinical guidelines for sepsis and septic shock. PMCID: PMC7194587.

```